Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Moderna share price doubles on melanoma vaccine trial success

Financial Times

BusinessFinancial Times·Aug 19, 2026·1 min read

Moderna share price doubles on melanoma vaccine trial success

Company’s melanoma cancer vaccine being developed with Merck

View original source — Financial Times ↗

ShareShare on X Share on Facebook

Related stories

BusinessAug 19, 2026 · 1 min

Arsenal chief calls for clarity on Man City charges

BusinessAug 19, 2026 · 1 min

Unitree's viral dancing, rollerblading robots make a 600% stock market debut

BusinessAug 19, 2026 · 1 min

Putin calls Russia’s economic growth modest but positive

I’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?

BusinessAug 19, 2026 · 1 min

I’m leaving my grandkids money — but they must pass financial-literacy classes to get it. Is that fair?